Covered recipient · General Payments record
LATOYA C NOTTAGE-MURPHY
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2023
$242.16
- Reported across 10 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $242.16 | 10 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Tris Pharma Inc | $102.60 | 1 |
| ITI, Inc. | $47.88 | 3 |
| Noven Therapeutics, LLC | $31.30 | 2 |
| ABBVIE INC. | $16.01 | 1 |
| Axsome Therapeutics, Inc. | $15.52 | 1 |
| Lundbeck LLC | $14.72 | 1 |
| Otsuka America Pharmaceutical, Inc. | $14.13 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2023 | $242.16 | 10 |
Payment records · PY2023 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.01 | 09/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998022991 | CMS |
| Axsome Therapeutics, Inc. | $15.52 | 11/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056177527 | CMS |
| ITI, Inc. | $14.89 | 09/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040643101 | CMS |
| ITI, Inc. | $18.35 | 10/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040643109 | CMS |
| ITI, Inc. | $14.64 | 10/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040643117 | CMS |
| Lundbeck LLC | $14.72 | 11/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032303003 | CMS |
| Noven Therapeutics, LLC | $14.59 | 09/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1028340235 | CMS |
| Noven Therapeutics, LLC | $16.71 | 10/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1028340245 | CMS |
| Otsuka America Pharmaceutical, Inc. | $14.13 | 10/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014643175 | CMS |
| Tris Pharma Inc | $102.60 | 09/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059403069 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023
- Source files
- Dataset page · Bulk file · PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.